(28 days)
Not Found
No
The 510(k) summary describes a purely mechanical suture anchor and inserter system with no mention of AI or ML capabilities.
Yes
The device is described as stabilizing damaged soft tissue in conjunction with postoperative immobilization throughout the healing period, which indicates a therapeutic purpose.
No
The device is a bioabsorbable suture anchor used in orthopedic surgical procedures to reattach soft tissue to bone, which is a therapeutic function, not diagnostic.
No
The device description clearly outlines a physical, bioabsorbable suture anchor made of Poly L-lactic Acid, preloaded on a disposable inserter device with sutures. This is a hardware medical device, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices that are used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- Device Description and Intended Use: The provided description clearly states that this device is a suture anchor intended for surgical procedures to reattach soft tissue to bone. It is a physical implant used within the body during surgery.
The device's function is mechanical and structural, not diagnostic based on analyzing biological samples.
N/A
Intended Use / Indications for Use
The anchors are intended to reattach soft tissue to bone in orthopedic surgical procedures. The device may be used in either arthroscopic or open surgical procedures. After the suture is anchored to the bone, it may be used to reattach soft tissue, such as ligaments, tendons, or joint capsules, to the bone. The suture anchor system thereby stabilizes the damaged soft tissue, in conjunction with appropriate postoperative immobilization, throughout the healing period.
Product codes
MAI
Device Description
The proposed device is a bioabsorbable push-in (press fit) suture anchor that is preloaded on a disposable inserter device with one or two non-absorbable. braided, polyethylene sutures. The proposed device is manufactured from 100% Poly L-lactic Acid with colorant D&C violet #2. The polymer is inert and noncollagenous through the absorption process. The device dimensions are 2.9mm diameter and 10.75mm in length.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone (to reattach soft tissue such as ligaments, tendons, or joint capsules)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
orthopedic surgical procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
510(k) SUMMARY
ConMed Linvatec Presto ™, Preloaded with one or two #2 Hi-Fi® Sutures
In accordance with the requirements of the Safe Medical Device Act of 1990 and 21 CFR 807.92, ConMed Linvatec is hereby submitting the 510(k) Summary of Safety and Effectiveness for the 510(k) Number K092898.
Submitter A.
OCT 1 7 2009
ConMed Linvatec 11311 Concept Boulevard Largo, Florida 33773-4908 Registration Number: 1017294
Company Contact B.
Lorna Linville Regulatory Affairs Manager Phone: 727-399-5396 Fax: 727-399-5264
C. Device Name
| Trade Name: | ConMed Linvatec Presto, Preloaded with one or |
|---|---|
| two #2 Hi-Fi® Sutures | |
| Common Name: | Bioabsorbable suture anchor |
| Classification Name: | Single/multiple component metallic bone |
| fixation appliances and accessories | |
| Proposed Class/Device: | Class II |
| Product Code: | MAI |
| Regulation: | 21 CFR Part 888.3030 |
Predicate/Legally Marketed Devices D.
| Device Name: | ConMed Linvatec Bio Mini-Revo Suture Anchor |
|---|---|
| Company Name: | ConMed Linvatec |
| 510(k) #: | K053561 |
| TY --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | Canlind Tinustan Rin Anchor |
ConMed Linvatec BioAnchor Device Name: ConMed Linvatec Company Name: K042778 510(k) #:
162
1
E. Device Description
The proposed device is a bioabsorbable push-in (press fit) suture anchor that is preloaded on a disposable inserter device with one or two non-absorbable. braided, polyethylene sutures. The proposed device is manufactured from 100% Poly L-lactic Acid with colorant D&C violet #2. The polymer is inert and noncollagenous through the absorption process. The device dimensions are 2.9mm diameter and 10.75mm in length.
F. Intended Use/ Indications
The anchors are intended to reattach soft tissue to bone in orthopedic surgical procedures. The device may be used in either arthroscopic or open surgical procedures. After the suture is anchored to the bone, it may be used to reattach soft tissue, such as ligaments, tendons, or joint capsules, to the bone. The suture anchor system thereby stabilizes the damaged soft tissue, in conjunction with appropriate postoperative immobilization, throughout the healing period.
G. Substantial Equivalence . . . . . . . . .
The proposed device is substantially equivalent in design, manufacturing materials, intended use, principles of operation, and technical characteristics to the identified predicate devices K053561 and K042778.
2 of 2
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is enclosed within a circular border, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" arranged around the upper half of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
ConMed Linvatec % Ms. Loma K. Linville Regulatory Affairs Manager 11311 Concept Boulevard Largo, Florida 33773-4908
OCT 1 7 2009
Re: K092898
Trade/Device Name: ConMed Linvatec Presto™, Preloaded with one or two #2 Hi-Fi Sutures Regulation Number: 21 CFR 888.3030
Regulation Name: Single/multiple component metallic bone fixation appliances and accessories
Regulatory Class: II Product Code: MAI Dated: September 18, 2009 Received: September 21, 2009
Dear Ms. Linville:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events} (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2- Ms. Lorna K. Linville
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Mishranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark A. Millhurn
Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
Ko92898
510(k) Number (if known):
ConMed Linvatec Presto™, Preloaded with one or two #2 Hi-Fi Device Name: Sutures
Indications for Use:
1 - 1 - 1 - 1 - 1 - 1 - 1 - 1 - 1
The anchors are intended to reattach soft tissue to bone in orthopedic surgical procedures. The device may be used in either arthroscopic or open surgical procedures. After the suture is anchored to the bone, it may be used to reattach soft tissue, such as ligaments, tendons, or joint capsules, to the bone. The suture anchor system thereby stabilizes the damaged soft tissue, in conjunction with appropriate postoperative immobilization, throughout the healing period.
Prescription Use X AND/OR (Part 21 CFR 801 Subpart D)
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE If NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Omete for mkm
(Division Sign Off)
Division of Surgical, Onthopedic. and Restorative Devices
510(k) Number K092898